What this is
- () can harm male reproductive health, causing oxidative stress and inflammation.
- This research evaluates the protective effects of () from Monascus purpureus against HANP-induced testicular injury in male rats.
- Rats were treated with and varying doses of to assess improvements in semen quality, hormone levels, and testicular health.
Essence
- from Monascus purpureus effectively protect male rats from testicular damage induced by . The highest dose restored reproductive function and reduced oxidative stress.
Key takeaways
- HANP exposure significantly reduced sperm motility to 14.00±4.94% and viability to 17.50±2.74%, while increasing abnormal spermatozoa to 58.33±10.05% compared to control values. This indicates marked reproductive impairment.
- Co-administration of at 40 mg/kg restored sperm motility to 57.75±4.43% and viability to 57.75±12.09%, demonstrating a dose-dependent protective effect against HANP-induced toxicity.
- HANP exposure significantly elevated caspase-3 activity to 33.85±3.05 U/mg and NF-κB levels to 91.64±26.32 pg/mg. co-treatment reduced these markers, indicating decreased inflammation and apoptosis.
Caveats
- The study was conducted in a rodent model, which may not fully represent human exposure scenarios. Further research is needed to validate these findings in clinical settings.
- Molecular docking analyses provide supportive evidence for interactions with autophagy-related proteins but lack direct biochemical validation.
Definitions
- hydroxyapatite nanoparticles (HANPs): Nanoscale particles of hydroxyapatite, a biocompatible material used in biomedical applications, which can induce oxidative stress and reproductive toxicity.
- red pigments (RP): Bioactive compounds derived from Monascus purpureus, known for their antioxidant and anti-inflammatory properties.
Simplified
Introduction
Hydroxyapatite, a calcium phosphate compound with the formula Ca₁₀(PO₄)₆(OH)₂, is a naturally occurring bioceramic material that closely mimics the mineral component of bone and teeth. It can be synthesized via various methods, including precipitation, hydrolysis, and hydrothermal synthesis, or derived from natural sources such as fish bones, eggshells, and marine shells1,2. In its nanoparticulate form, hydroxyapatite nanoparticles (HANPs) have gained widespread attention in biomedical and biotechnological fields due to their unique physicochemical properties and high biocompatibility. Applications of HANPs include their use as drug carriers, implant coatings, and imaging agents3.
Despite their promising applications, the increasing use of HANPs has raised concerns regarding potential adverse effects on human health and the environment. HANPs have been shown to induce cytotoxic effects primarily through the generation of reactive oxygen species (ROS), leading to oxidative stress, inflammation, and genotoxicity4–6. Their interactions with critical biomolecules, including DNA and cytochrome enzymes, and potential accumulation in vital organs underscore the importance of careful toxicological evaluation7. Recent evidence indicates that HANPs can negatively affect the male reproductive system, impairing spermatogenesis, hormone secretion, mitochondrial function, and overall semen quality8.
Male infertility affects nearly 15% of the global population and is steadily increasing worldwide, with projections indicating a more rapid rise in the future9. Consequently, there is growing interest in identifying protective agents capable of mitigating reproductive toxicity, particularly those targeting oxidative damage and dysregulated autophagic signaling pathways, which are increasingly recognized as key contributor to testicular dysfunction10,11. In this context, naturally derived bioactive compounds with well-characterized antioxidant, anti-inflammatory, and cytoprotective activities are actively being investigated as complementary or preventive strategies to mitigate toxicant-induced reproductive damage, owing to their multi-target mechanisms of action and comparatively favorable safety profiles12–14.
One such promising candidate is Monascus purpureus, an ascomycetous fungus traditionally used in East and Southeast Asia for food fermentation. It produces a range of secondary metabolites, including a group of pigmented polyketides, namely red, orange, and yellow pigments, which possess various biological properties such as antioxidant, antimicrobial, anti-inflammatory, and cholesterol-lowering effects15,16. Red pigments (RP) such as rubropunctamine and monascorubramine have domonstrated notable potential in mitigating oxidative stress and inflammation, positioning them as promising candidates for protective interventions against nanoparticle-induced toxicity. In our previous laboratory’s experimental series, utilizing the same batch of animals and consistent dosing regimens, we evaluated the systemic protective effects of these pigments against the renal and hepatic toxicity induced by HANPs17,18. Despite these promising attributes, there remains a lack of comprehensive data regarding the protective role of M. purpureus RP against nanomaterial-induced reproductive toxicity. In particular, little is known about their modulatory effect on critical molecular pathways such as autophagy19, which plays a vital role in testicular homeostasis and spermatogenesis.
Given the established reproductive toxicity of HANPs and the bioactive potential of M. purpureus RPs, this study investigated their protective effects against HANP-induced testicular damage in adult male rats. The work evaluated semen quality, reproductive hormone profiles, testicular histopathology, and the expression of key autophagy-related genes, including Beclin1, LC3B, ULK1, and ATG9, to elucidate the underlying mechanisms. Complementary molecular docking analyses were conducted to explore potential interactions between the major RP constituents, monascorubramine and rubropunctamine, and autophagy-related molecular targets.
Materials and methods
Chemicals and materials
HANPs (white nano powder, size = 100 ± 30 nm, length = 20 ± 5 nm) were obtained from Nanotech Egypt Co. (Giza, Egypt). All chemicals were of high quality and analytical grade.
Physicochemical characterization of HANPs and RPs
In our previous study, HANPs were characterized using high-resolution transmission electron microscopy (HR-TEM), Fourier-transform infrared spectroscopy (FTIR), and X-ray diffraction (XRD) to assess their morphology, functional groups, and crystalline structure17. Likewise, Monascus RP, extracted with ethanol from M. purpureus strain ATCC16436, was analyzed using UV–Visible spectroscopy, FTIR, and liquid chromatography–mass spectrometry (LC-MS). Detailed methodologies and instrumental parameters are provided in our earlier publication17.
Experimental animal set up
Forty-eight adult male Wistar rats (180–200 g) were procured from the Faculty of Medicine, Alexandria University, Egypt. The animals were maintained under standard laboratory conditions: a controlled temperature of 25 ± 5 °C, relative humidity of 50–60%, and a 12-hour light/dark cycle. They had unrestricted access to a basal diet and tap water. Following a two-week acclimatization period, the rats were randomly assigned into eight equal groups (n = 6), each receiving a specific treatment. HANPs were administered at a dose of 88.3 mg/kg body weight, as per Nair and Jacob20, based on preliminary dose- optimization trials and literature evidence, demonstrating biological efficacy without inducing observable toxicity. M. purpureus RP was administered at three dose levels: 10 mg/kg (low dose), 20 mg/kg (intermediate dose based on Zhou et al.21, and 40 mg/kg (high dose), representing half, equal to, and double the reference dose, respectively. The experimental groups and their treatments were as follows: Control group: Received 4% dimethyl sulfoxide (DMSO), the solvent for HANPs; RP10 group: Received 10 mg/kg RP; RP20 group: Received 20 mg/kg RP; RP40 group: Received 40 mg/kg RP; HANPs group: Received 88.3 mg/kg HANPs; RP10 + HANPs group: Co-treated with 10 mg/kg RP and 88.3 mg/kg HANPs; RP20 + HANPs group: Co-treated with 20 mg/kg RP and 88.3 mg/kg HANPs; RP40 + HANPs group: Co-treated with 40 mg/kg RP and 88.3 mg/kg HANPs. All treatments were administered once daily via oral gavage for a duration of 50 consecutive days.
All experimental procedures were carried out in accordance with ARRIVE guidelines and the Guide for the Care and Use of Laboratory animals (International Council for Laboratory Animal Science, ICLAS) under the approval number AU14-211017-2-10 provided by the institutional animal care and use committee (IACUC) at Alexandria University, Egypt.
Blood and organ collection
At the end of the experiment, the rats were fasted overnight and sacrificed under anesthesia using 3% isoflurane inhalation, with every effort taken to minimize discomfort17. Blood samples were collected via cardiac puncture into heparinized test tubes. Serum was separated by centrifugation at 860 x g for 20 min and stored at -20 °C until further analysis. Testes were carefully removed, freed from adherent tissues, rinsed in chilled 0.9% saline solution, and blotted dry with tissue paper. A portion of the tissue was immediately fixed in 10% formalin for histological examination. The remaining tissue was minced and homogenized (10%, w/v) in ice-cold phosphate buffer (0.25 M, pH 7.4) using a Potter–Elvehjem homogenizer. The homogenates were centrifuged at 10,000 x g for 20 min at 4 °C to remove cellular debris. The resulting supernatant was collected and stored at − 80 °C for subsequent biochemical analyses.
Determination of semen characteristics
Epididymal sperm was collected for fertility assessment, including sperm motility, viability, morphological evaluation, and sperm count. Analyses were performed using an automated Computer-Assisted Semen Analysis (CASA) system (Germany), which provides objective and reproducible measurements of sperm parameters. This approach allows simultaneous evaluation of multiple sperm characteristics, minimizing observer bias22.
Hormonal assays
Serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and testosterone were measured using commercially available enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturers’ instructions (Cusabio, USA). FSH levels were determined using the ELISA kit (Catalog No. CSB-E06869r). LH concentrations were assessed with the ELISA kit (Catalog No. CSB-E12654r). Testosterone levels were quantified using the rat Testosterone ELISA Kit (Catalog No. CSB-E05100r). All assays were performed in duplicate to ensure accuracy and reproducibility.
Determination of inflammatory and apoptotic markers
The concentration of nuclear factor-kappa B (NF-κB) in tissue homogenates was quantified using a commercially available sandwich ELISA kit (Cat. No. BYEK3040; Chongqing Biospes Co., Ltd, China), according to the manufacturer’s protocol. The enzymatic reaction produced a color change, which was terminated by adding an acidic stop solution. Absorbance was measured at 450 nm using a microplate reader, and NF-κB concentrations were calculated based on a standard curve.
Tissue caspase-3 activity, an established marker of apoptosis, was assessed using a colorimetric Caspase-3 Activity Assay Kit (Elabscience, USA) following the manufacturer’s instructions. The release of p-nitroaniline (pNA) from the caspase-3-specific substrate was quantified by measuring absorbance at 405 nm, which is directly proportional to the enzymatic activity of caspase-3 in the sample.
Assessment of redox markers
Total protein content in testicular tissue samples was measured using a modified Lowry method, as described by Lowry et al.23. This colorimetric assay is based on the formation of a blue complex between copper ions and the tyrosine and tryptophan residues of proteins under alkaline conditions. Protein concentrations were calculated from a standard curve constructed using bovine serum albumin (BSA) as the reference standard.
Lipid peroxidation in tissue samples was evaluated by measuring malondialdehyde (MDA) levels, expressed as thiobarbituric acid reactive substances (TBARS), according to the method of Draper and Hadley24. In this assay, the sample is heated under acidic conditions with thiobarbituric acid (TBA), resulting in the formation of a pink chromogen with maximal absorbance at 532 nm, which is directly proportional to the MDA concentration.
Reduced glutathione (GSH) and oxidized glutathione (GSSG) levels in testicular homogenates were quantified enzymatically using the method of Griffith25. This method allows for the determination of total glutathione content and the specific quantification of GSSG after derivatization, providing insight into the tissue redox balance.
Expression analysis of key autophagy-related genes using quantitative real time-polymerase chain reaction (qRT-PCR)
Total RNA was isolated using RNeasy mini kit (Qiagen, Hilden, Germany) and reverse transcribed into cDNA using miScript II reverse transcriptase (Qiagen, Hilden, Germany). Real-time PCR using specific primer sets for Beclin-1 (Accession Nº NM_001034117.1↗; sense: TTG GCC AAT AAG ATG GGT CTG AA, antisense: TGT CAG GGA CTC CAG ATA CGA GTG), LC3B (Accession Nº NM_022867.2↗; sense: CAG GAT CCA TGC CGT CCC AGA AGA CC, antisense: GTC CCT TTT TGC CTT GGT AG), ULK1 (Accession Nº NM_001108341.1↗; sense: CAT CCG AAG GTC AGG TAG CA, antisense: GAT GGT TCC CAC TTG GGG AGA), and ATG9 (Accession Nº NM_001014218↗; sense: CCC ACG GGC CCT GGA GAT CA, antisense: CCG TGC TGG CGA ACG TCC AT), was performed using SYBR green (Qiagen, Hilden, Germany) and 18s rRNA (Accession Nº NR_046237.2↗; sense primer: GTA ACC CGT TGA ACC CCA TT; antisense primer: CAA GCT TAT GAC CCG CAC TT) as a reference gene in a LightCycler machine (Roche, Basel, Switzerland).
Molecular docking analysis
Molecular docking is a powerful computational technique used to evaluate the energetic and geometric compatibility of a ligand within the active site of a protein. The three-dimensional (3D) structures of the investigated compounds were generated using Gaussian 09 software and subsequently converted into Protein Data Bank (PDB) format for docking analysis26. The crystal structure of the target LC3B receptor (PDB ID: 5WRD) was retrieved from the RCSB PDB (http://www.rcsb.org↗). Molecular docking simulations were carried out to assess binding affinities and interaction profiles, while validation was achieved through re-docking of co-crystallized ligand to ensure the accuracy and reliability of the computational protocol27.
Histopathology examination
Tissue sections of fixed testicular tissues (10% formalin ) with a thickness of 4–6 μm were mounted on poly-L-lysine-coated slides. The sections were deparaffinized using xylene and rehydrated through a graded series of ethanol solutions. Afterward, they were stained with hematoxylin and counterstained with eosin for histological examination. Photographs were captured using an Olympus XC30 microscope (Germany) equipped with a digital camera (Olympus UC30 camera). Representative images were taken at 100x and 400x magnification from each group.
Statistical analysis
Data were coded and analyzed using SPSS version 22.0. The assumptions of parametric tests were verified, and the normality of continuous variables was assessed using the Shapiro–Wilk and Kolmogorov–Smirnov tests. Probability and percentage data were normalized using the arcsine square root transformation. Results were expressed as mean ± standard deviation (SD). Each experimental group included at least six replicates. Post hoc comparisons were performed using Tukey’s test following one-way ANOVA.
Results
Semen characteristics under different treatment protocols
The effects of M. purpureus RP and HANPs on semen parameters are presented in Table 1; Fig. 1A-D. Rats treated with RP alone at doses of 10, 20, or 40 mg/kg showed no statistically significant changes in sperm motility, viability, sperm count, or abnormal morphology compared with the control group. In contrast, exposure to HANPs (88.3 mg/kg) led to a marked deterioration in all semen parameters. Specifically, sperm motility dropped significantly to 14.00 ± 4.94%, viability to 17.50 ± 2.74%, and sperm count to 26.33 ± 5.16 per 10⁶/mL, while the percentage of abnormal spermatozoa rose sharply to 58.33 ± 10.05%, compared to 79.00 ± 7.27%, 87.00 ± 5.22%, 95.00 ± 5.22 per 10⁶/mL, and 7.83 ± 2.48% respectively in the control group.
Co-administration of RP with HANPs resulted in a dose-dependent improvement in all semen parameters. At the lowest RP dose (10 mg/kg), sperm motility and count increased to 26.50 ± 11.06% and 34.00 ± 7.72 per 10⁶/mL, respectively, while abnormalities decreased to 37.83 ± 6.01%. The intermediate RP dose (20 mg/kg) further improved motility (48.67 ± 11.98%) and sperm count (55.17 ± 12.02 per 10⁶/mL) with a concurrent decline in abnormal forms (26.00 ± 9.74%). The highest dose (40 mg/kg) showed the most pronounced protective effect, significantly restoring sperm motility (57.75 ± 4.43%), viability (57.75 ± 12.09%), and count (69.00 ± 9.87 per 10⁶/mL), along with a marked reduction in abnormalities (18.75 ± 2.75%) compared with the HANPs-only group. These findings highlight the potential of RP to mitigate HANP-induced reproductive toxicity in a dose-dependent manner.
Box-plot representing semen characteristics in testicular tissues of the different studied groups. () Motility, () Viability, () Abnormality, and () Sperm count. HANPs: hydroxyapatite nanoparticles; RP: red pigment of. Data are presented as mean ± SD (= 6). A B C D Monascus purpureus n
| Treatments | Motility% | Viability% | Abnormality% | Sperm Count (×10⁶/mL) |
|---|---|---|---|---|
| Control group | 79.00 ± 7.27ab | 87.00 ± 5.22a | 7.83 ± 2.48c | 95.00 ± 5.22a |
| RP10 group | 76.00 ± 8.44ab | 80.00 ± 6.57ab | 9.17 ± 2.56c | 88.17 ± 10.05a |
| RP20 group | 87.33 ± 8.17a | 83.00 ± 5.62ab | 8.17 ± 1.47c | 92.50 ± 6.44a |
| RP40 group | 62.25 ± 35.62ab | 60.88 ± 27.37bc | 18.63 ± 21.04c | 74.50 ± 31.76ab |
| HANPs group | 14.00 ± 4.94d | 17.50 ± 2.74e | 58.33 ± 10.05a | 26.33 ± 5.16d |
| RP10 + HANPs group | 26.50 ± 11.06cd | 27.00 ± 6.13de | 37.83 ± 6.01b | 34.00 ± 7.72cd |
| RP20 + HANPs group | 48.67 ± 11.98bc | 46.50 ± 10.27cd | 26.00 ± 9.74bc | 55.17 ± 12.02bc |
| RP40 + HANPs group | 57.75 ± 4.43bc | 57.75 ± 12.09bc | 18.75 ± 2.75bc | 69.00 ± 9.87ab |
Evaluation of reproductive hormones across various treatment protocols
The effects of RP and HANPs on reproductive hormones are illustrated in Fig. 2A-C; Table 2. Administration of RP alone at doses of 10, 20, or 40 mg/kg did not significantly alter serum testosterone, FSH, or LH levels compared to the control group. However, exposure to HANPs resulted in a pronounced hormonal disturbance, characterized by a significant decline in testosterone levels (2.70 ± 0.64 ng/mL vs. 5.01 ± 0.55 ng/mL in control), accompanied by elevated FSH and LH levels (1.30 ± 0.10 and 0.62 ± 0.05 mIU/mL vs. 1.01 ± 0.16 and 0.44 ± 0.06 mIU/mL in control, respectively).
Co-supplementation with RP led to a dose-dependent restoration of hormonal balance. At the highest RP dose (40 mg/kg), testosterone levels improved substantially (4.61 ± 0.42 ng/mL), while FSH and LH levels declined to near-control values (0.98 ± 0.09 and 0.48 ± 0.04 mIU/mL, respectively), indicating a strong protective effect. These results suggest that RP effectively mitigates HANP-induced reproductive endocrine disruption in a dose-dependent manner.
Column chart showing reproductive hormone levels in the serum of the different studied groups: () testosterone, () follicle-stimulating hormone (FSH), and () luteinizing hormone (LH). HANPs: hydroxyapatite nanoparticles; RP: red pigment of. A B C Monascus purpureus
| Treatments | Total Testosterone (ng/mL) | FSH (mIU/mL) | LH (mIU/mL) |
|---|---|---|---|
| Control group | 5.01 ± 0.55ab | 1.01 ± 0.16b | 0.44 ± 0.06b |
| RP10 group | 5.08 ± 0.32a | 0.98 ± 0.18b | 0.45 ± 0.03b |
| RP20 group | 5.14 ± 0.28a | 1.00 ± 0.10b | 0.45 ± 0.03b |
| RP40 group | 4.82 ± 1.37ab | 1.09 ± 0.17ab | 0.51 ± 0.08b |
| HANPs group | 2.70 ± 0.64c | 1.30 ± 0.10a | 0.62 ± 0.05a |
| RP10 + HANPs group | 3.76 ± 0.58bc | 1.16 ± 0.09ab | 0.53 ± 0.04ab |
| RP20 + HANPs group | 4.58 ± 0.38ab | 1.12 ± 0.09ab | 0.51 ± 0.05b |
| RP40 + HANPs group | 4.61 ± 0.42ab | 0.98 ± 0.09b | 0.48 ± 0.04b |
Assessment of testicular inflammatory and apoptotic markers across various treatment protocols
As shown in Table 3; Fig. 3A and B, supplementation with different doses of RP alone (10, 20, and 40 mg/kg) did not cause significant changes in caspase-3 or NF-κB levels compared with the control group. In contrast, exposure to HANPs markedly elevated both caspase-3 (33.85 ± 3.05 U/mg) and NF-κB (91.64 ± 26.32 pg/mg) compared with controls (6.55 ± 1.31 U/mg and 5.35 ± 0.58 pg/mg, respectively). Co-supplementation of RP with HANPs significantly reduced these elevations in a dose-dependent manner. The most pronounced attenuation was observed with the highest RP dose, which lowered caspase-3 to 20.35 ± 3.04 U/mg and NF-κB to 26.47 ± 4.49 pg/mg, although these values remained notably higher than the normal control levels.
Area chart representing apoptotic and inflammatory markers in testicular tissues of the different studied groups: () caspase-3 activity and () nuclear factor-kappa B (NF-κB) content. HANPs: hydroxyapatite nanoparticles; RP: red pigment of. A B Monascus purpureus
| Treatments | Caspace- 3(U/mg) | NF-kb(pg/mg) |
|---|---|---|
| Control group | 6.55 ± 1.31d | 5.35 ± 0.58c |
| RP10 group | 8.06 ± 1.00cd | 6.66 ± 1.46c |
| RP20 group | 7.87 ± 0.93cd | 9.64 ± 2.30c |
| RP40 group | 16.85 ± 13.43bcd | 36.88 ± 44.16bc |
| HANPs group | 33.85 ± 3.05a | 91.64 ± 26.32a |
| RP10 + HANPs group | 26.14 ± 4.03ab | 59.01 ± 13.61ab |
| RP20 + HANPs group | 21.01 ± 2.85b | 41.28 ± 13.36bc |
| RP40 + HANPs group | 20.35 ± 3.04bc | 26.47 ± 4.49bc |
Assessment of redox markers in the different experimental animal groups
As presented in Table 4; Fig. 4A-F, RP supplementation alone at any tested dose did not significantly alter redox parameters relative to controls. HANPs exposure significantly increased MDA levels (7.15 ± 1.39 nmol/mg tissue vs. 3.03 ± 0.23 nmol/mg tissue in controls) and oxidized GSSG (0.65 ± 0.04 nmol/mg protein vs. 0.30 ± 0.02 nmol/mg protein), while markedly decreasing total GSH (3.59 ± 0.28 nmol/mg protein vs. 5.62 ± 0.42 nmol/mg protein), reduced GSH (2.28 ± 0.34 nmol/mg protein vs. 5.01 ± 0.48 nmol/mg protein), and the GSH/GSSG ratio (3.52 ± 0.62 vs. 16.53 ± 0.95 in controls). Co-supplementation of RP with HANPs significantly and dose-dependently restored antioxidant capacity, evidenced by higher total GSH, reduced GSH, and GSH/GSSG ratio, along with decreased MDA and oxidized GSSG compared with HANPs alone. The highest RP dose produced the greatest improvement, with MDA reduced to 4.00 ± 0.15 nmol/g tissue and GSH/GSSG ratio increased to 10.92 ± 1.11.
Line chart representing redox status in testicular tissues of the different studied groups: () malondialdehyde (MDA) content, () total glutathione (GSH) content, () oxidized glutathione (GSSG) content, () reduced glutathione content, and () GSH/GSSG ratio. HANPs: hydroxyapatite nanoparticles; RP: red pigment of. A B C D E Monascus purpureus
| Treatments | MDA (nmol/mg) | Total GSH (µmol/mg) | Oxidized GSSG Conc. (nmol/mg) | Reduced GSH Conc. (nmol/mg) | GSH/GSSG |
|---|---|---|---|---|---|
| Control group | 3.03 ± 0.23b | 5.62 ± 0.49a | 0.30 ± 0.02c | 5.01 ± 0.48a | 16.53 ± 1.08a |
| RP10 group | 3.06 ± 0.38b | 5.92 ± 0.44a | 0.33 ± 0.02cd | 5.26 ± 0.44a | 15.85 ± 1.05a |
| RP20 group | 3.17 ± 0.23b | 6.05 ± 0.45a | 0.34 ± 0.02cd | 5.37 ± 0.40a | 15.90 ± 1.18a |
| RP40 group | 4.52 ± 2.28b | 5.48 ± 1.26a | 0.35 ± 0.02c | 5.43 ± 0.39a | 12.38 ± 5.65ab |
| HANPs group | 7.15 ± 1.39a | 3.95 ± 0.59b | 0.65 ± 0.04d | 2.28 ± 0.34c | 5.22 ± 2.59c |
| RP10 + HANPs group | 4.86 ± 0.57b | 5.00 ± 0.35ab | 0.46 ± 0.04d | 3.92 ± 0.36b | 9.23 ± 1.46bc |
| RP20 + HANPs group | 4.18 ± 0.28b | 5.09 ± 0.32ab | 0.43 ± 0.02dc | 4.26 ± 0.34b | 9.92 ± 1.12bc |
| RP40 + HANPs group | 4.03 ± 0.16b | 5.22 ± 0.34ab | 0.40 ± 0.03c | 4.36 ± 0.28b | 11.36 ± 1.39ab |
Assessment of autophagy-related gene expression (,,,) across various treatment protocols Beclin-1 LC3B ULK1 ATG9
As illustrated in Fig. 5A-D; Table 5, RP supplementation alone did not significantly alter the expression of Beclin-1, LC3B, ULK1, or ATG9 compared with controls. HANPs exposure markedly upregulated these autophagy-related genes (Beclin-1: 2.99 ± 0.41; LC3B: 3.50 ± 1.33; ULK1: 1.52 ± 0.13; ATG9: 2.01 ± 0.55 fold change) relative to control values. Co-supplementation with RP significantly downregulated their expression in a dose-dependent manner compared with HANPs alone. The most substantial normalization was achieved with 40 mg/kg RP, reducing Beclin-1 to 1.73 ± 0.04, LC3B to 1.53 ± 0.08, ULK1 to 1.20 ± 0.17, and ATG9 to 1.55 ± 0.27 fold change, closely approaching control levels.
Radar chart showing autophagy-related gene expression in testicular tissues of the different studied groups under various treatment protocols: () Beclin-1, () LC3B, () ULK1, and () ATG9. HANPs: hydroxyapatite nanoparticles; RP: red pigment of; LC3B: microtubule-associated protein light chain 3; ULK1: Unc-51-like autophagy-activating kinase 1; ATG9: autophagy-related protein 9. A B C D Monascus purpureus
| Treatments | Beclin-1 | LC3B | ULK1 | ATG9 |
|---|---|---|---|---|
| Control group | 1.00 ± 0.05c | 1.00 ± 0.24b | 1.00 ± 0.24b | 1.00 ± 0.25bc |
| RP10 group | 0.98 ± 0.09c | 0.94 ± 0.18b | 1.15 ± 0.20ab | 0.89 ± 0.14c |
| RP20 group | 0.90 ± 0.08c | 1.03 ± 0.31b | 1.22 ± 0.14ab | 0.97 ± 0.10bc |
| RP40 group | 1.53 ± 1.19bc | 1.68 ± 1.11b | 1.35 ± 0.23ab | 1.80 ± 0.61a |
| HANPs group | 2.99 ± 0.41a | 3.50 ± 1.33a | 1.52 ± 0.13a | 2.01 ± 0.55a |
| RP10 + HANPs group | 2.10 ± 0.26ab | 1.63 ± 0.23b | 1.44 ± 0.20a | 1.62 ± 0.10ab |
| RP20 + HANPs group | 1.85 ± 0.15bc | 1.63 ± 0.21b | 1.39 ± 0.26ab | 1.52 ± 0.20ab |
| RP40 + HANPs group | 1.73 ± 0.04bc | 1.53 ± 0.08b | 1.20 ± 0.17ab | 1.55 ± 0.27abc |
Docking interaction against the active site of the target protein,(PDB ID: 5WRD) LC3B
Molecular docking studies were performed to evaluate the binding interactions of monascorubramine and rubropunctamine with the LC3B receptor (PDB ID: 5WRD), using Glycerol (GOL) as the control ligand (Table 6; Fig. 6). The control ligand, GOL, displayed moderate interaction within the LC3B active site, forming hydrogen donor and acceptor bonds with residues THR50, ARG37, and ARG10, with bond lengths ranging from 2.99 to 3.30 Å and an overall docking energy score of − 4.0867 kcal/mol.
Monascorubramine exhibited the highest binding affinity among the tested compounds, characterized by a strong hydrogen acceptor bond with ARG37 at a bond length of approximately 2.95 Å and an affinity bond strength of − 3.4 kcal/mol, resulting in a docking energy score of − 6.8395 kcal/mol. Rubropunctamine also demonstrated a stable interaction through a hydrogen acceptor bond with ARG37 (3.11 Å, − 0.7 kcal/mol), achieving a docking score of − 6.6515 kcal/mol.
The binding affinities of monascorubramine and rubropunctamine were markedly higher than that of the control ligand, indicating stronger and more stable interactions with the LC3B active site. The ranking of binding energies followed the order: monascorubramine > rubropunctamine > GOL, suggesting that monascorubramine in particular may form a more energetically favorable complex with LC3B.
Two- and three-dimensional molecular docking representations showing the binding interactions of the co-crystallized control ligand (GOL), monascorubramine, and rubropunctamine within the active site of the LC3B receptor (PDB ID: 5WRD).
| Compound | Ligand | Amino acids | Interaction | Affinity bond length(in Afrom main residue)o | Affinity bond strength(Kcal/mol) | Energy score (Kcal/mol) |
|---|---|---|---|---|---|---|
| Control ligand (GOL) | O13 | THR50 | H-donor | 2.99 | -1 | -4.0867 |
| O8 | ARG37 | H-acceptor | 3.18 | -1.6 | ||
| O13 | ARG10 | H-acceptor | 3.3 | -0.8 | ||
| Monascorubramine | O17 | ARG37 | H-acceptor | 2.95 | -3.4 | -6.8395 |
| Rubropunctamine | O48 | ARG37 | H-acceptor | 3.11 | -0.7 | -6.6515 |
Effects of variable doses of RP, alone or in combination with HANPs, on testicular histopathology
Histological assessment of the testicular sections revealed that both the control group and rats supplemented with M. purpureus RP alone at all tested doses (10, 20, and 40 mg/kg) exhibited normal seminiferous tubules and well-preserved interstitial tissue (Fig. 7). The testicular epithelium were intact, displaying complete spermatogenic series with clearly distinguishable spermatogerm stages, and no structural abnormalities were observed.
In contrast, the HANPs group showed marked histopathological alterations, including degeneration and vacuolation of the seminiferous tubules, atrophy of the interstitial tissue, and irregular integrity of the testicular epithelium with disrupted spermatogerm stages.
Co-supplementation of RP with HANPs revealed a dose-dependent amelioration of these histological changes. At the lowest RP dose, seminiferous tubules appeared irregular, with only slight improvement in degeneration and reduced interstitial tissue atrophy, alongside partial restoration of the epithelial architecture and spermatogerm stages. The intermediate RP dose showed more regular seminiferous tubules, further reduction of degenerative changes, and restoration of interstitial tissue and epithelial integrity. Notably, the highest RP dose preserved normal seminiferous tubule architecture with no visible degeneration, maintained healthy interstitial tissue, and restored a fully intact testicular epithelium with complete spermatogenic activity.
Representative photomicrographs of testicular tissue sections stained with H&E from the different experimental groups. The control andred pigment (RP; 10, 20, and 40 mg/kg) groups show normal seminiferous tubules and intact interstitial tissue with well-organized testicular epithelium and complete spermatogenic stages. In contrast, the HANPs group exhibits marked degeneration (D) and vacuolation (V) of seminiferous tubules, atrophy of interstitial tissue (black arrow), irregular epithelial lining (*), and disrupted spermatogenic series (G). Co-supplementation of RP with HANPs demonstrates a dose-dependent protective effect: the 10 mg/kg dose shows mild improvement with reduced degeneration and interstitial atrophy, the 20 mg/kg dose reveals more regular seminiferous tubules and improved epithelial integrity, while the 40 mg/kg dose largely restores normal testicular architecture with intact epithelium, healthy interstitial tissue, and complete spermatogenesis. Scale bars represent 400 μm at 100× magnification and 100 μm at 400× magnification. Monascus purpureus
Discussion
HANPs are widely recognized for their biomedical applications, including drug delivery, gene therapy, and molecular imaging28–30. Despite their benefits, accumulating evidence highlights their potential toxicity, particularly to the male reproductive system, due to their small size, high surface area, and ability to generate reactive oxygen species (ROS). In the present study, long-term oral exposure to HANPs induced marked reproductive toxicity in male rats, as evidenced by histological damage, impaired semen quality, hormonal imbalance, oxidative stress, inflammation, apoptosis, and altered autophagy-related gene expression. Collectively, these findings indicate the involvement of multiple interconnected pathways rather than a single dominant mechanism.
Histopathological examination revealed that HANPs exposure severely disrupted testicular architecture, with degeneration and vacuolation of seminiferous tubules, atrophy of interstitial tissue, and irregular epithelial lining with incomplete spermatogenic stages. These alterations were consistent with significant declines in sperm count, motility, and viability, accompanied by increased abnormal sperm forms. Such structural and functional impairments are likely interlinked, as normal seminiferous tubule architecture and Sertoli–Leydig cell integrity are crucial for spermatogenesis. These findings agree with previous reports that HANPs impair Leydig cell function, disrupt spermatogenesis, and reduce semen quality8.
The present study also demonstrated that HANP-induced testicular damage was strongly associated with oxidative stress. HANPs significantly increased MDA levels, reflecting enhanced lipid peroxidation, while depleting GSH and lowering the GSH/GSSG ratio. This oxidative imbalance compromises sperm membrane integrity, given the high content of polyunsaturated fatty acids in sperm membranes, and contributes to reduced motility, abnormal morphology, and cell death31. Moreover, oxidative injury to Leydig cells disrupts testosterone synthesis32,33, which in turn disturbs the hypothalamic–pituitary–gonadal axis, explaining the observed testosterone decline and compensatory increases in FSH and LH levels.
Inflammation appeared to be another key mechanism of HANP toxicity. Elevated NF-κB levels in the testes indicated activation of inflammatory signaling, which can impair the blood–testis barrier, disturb Sertoli cell function, and negatively affect spermatogenesis34–36. Parallel to inflammation, HANPs activated the apoptotic cascade, as shown by the marked increase in caspase-3 activity. While these data support activation of apoptotic signaling, the involvement of additional pro- and anti-apoptotic regulators was not examined in the present study. Given the known link between ROS overproduction and caspase activation37,38, it is plausible that oxidative stress served as the upstream trigger for apoptosis, leading to germ cell loss and testicular degeneration.
In addition to oxidative and inflammatory damage, HANPs induced a marked upregulation of autophagy-related genes (Beclin-1, LC3B, ULK1, and ATG9). While basal autophagy supports spermatogenesis by removing damaged organelles, excessive activation—especially under oxidative stress—can contribute to cell death and tissue injury11,39,40. These findings suggest dysregulation of autophagy rather than definitive activation of a complete autophagic flux, which would require assessment of additional markers such as ATG5 or SQSTM1/p62. This aligns with previous observations that nanoparticles can trigger both apoptosis and autophagy through ROS-mediated mitochondrial dysfunction and lysosomal damage41,42.
Co-supplementation with M. purpureus RP markedly ameliorated HANP-induced reproductive toxicity in a dose-dependent manner, with the most pronounced protective effects observed at 40 mg/kg. RP alone was well tolerated and preserved normal testicular histology, semen quality, and hormonal balance. When co-administered with HANPs, RP significantly improved seminiferous tubule organization, restored interstitial tissue integrity, and normalized the epithelial lining with complete spermatogenic stages at the highest dose. These histological improvements paralleled functional recovery, as reflected by enhanced sperm motility, viability, and count, along with reduced sperm abnormalities. Importantly, these findings align with the growing body of evidence supporting green nanotechnology, an emerging field that emphasizes the use of biologically derived materials for the synthesis, functionalization, and modulation of nanoparticle behavior43. Within this context, RP represents a promising natural product capable of counteracting the adverse reproductive effects of nanoparticle exposure, although its precise molecular targets remain to be fully elucidated.
Moreover, molecular docking simulations showed that both monascorubramine and rubropunctamine exhibited higher binding affinities to the LC3B receptor than the control ligand GOL, primarily through hydrogen bonding with the key residue ARG37. Monascorubramine demonstrated the strongest and most stable interaction, indicated by its shorter bond length and higher negative energy score, suggesting a greater potential to modulate LC3B activity. These in silico findings provide supportive, but not definitive, evidence for a potential interaction with LC3B and should be interpreted as hypothesis-generating rather than confirmatory.
Mechanistically, RP co-treatment significantly reduced lipid peroxidation, replenished GSH, improved the GSH/GSSG ratio, and lowered oxidized GSSG levels, indicating strong antioxidant activity. These effects are consistent with earlier findings that Monascus extracts possess potent free radical-scavenging and antioxidant enzyme-inducing properties16,17. By alleviating oxidative stress, RP may indirectly influence downstream inflammatory, apoptotic, and autophagy-related responses rather than acting as a direct regulator of these pathways. In line with reports demonstrating that environmental endocrine disruptors such as bisphenol-S trigger oxidative stress-driven NF-kB activation and caspase-dependent apoptosis44, our results showed significant reductions in inflammatory and apoptotic markers, along with normalization of autophagy-related gene expression, in RP-treated HANP groups.
The protective effects of RP are further supported by studies reporting that Monascus-fermented products improve reproductive parameters by enhancing antioxidant enzyme activity, restoring testosterone levels, and reducing ROS generation and caspase activation45. In addition to its antioxidant capacity, RP exerts anti-inflammatory effects through NF-κB pathway inhibition and anti-apoptotic actions via caspase suppression. Together, these mechanisms likely contribute to, but do not fully account for, the protective phenotype observed in the present study.
The present study has several limitations that should be acknowledged. First, the experimental exposure was conducted using oral gavage in a rodent model, which may not fully reflect the complexity of human exposure routes, doses, or durations associated with HANP contact. Second, although key pathways related to oxidative stress, inflammation, apoptosis, and autophagy were investigated, additional signaling and regulatory markers were not assessed and would provide deeper mechanistic insight in future studies. Third, the molecular docking analysis offers supportive in silico evidence of potential interactions with LC3B but does not substitute for direct biochemical or functional validation at the protein level. Finally, while the findings demonstrate a clear protective effect of Monascus purpureus RPs under controlled experimental conditions, extrapolation to clinical or environmental settings should be approached with caution, and future studies are required to confirm efficacy under exposure scenarios more relevant to human health.
Conclusion
In summary, HANP exposure induces male reproductive toxicity through interconnected mechanisms involving oxidative stress, inflammation, apoptosis, and dysregulated autophagy. Dietary supplementation with M. purpureus RP effectively mitigates these adverse effects in a dose-dependent manner, preserving testicular histology, sperm quality, and hormonal balance. These findings highlight the potential of RP as a natural, safe, and effective protective agent against nanoparticle-induced reproductive damage. Considering the growing use of HANPs in medical and industrial applications, such nutritional interventions could serve as a practical strategy to safeguard reproductive health and inform future translational studies.
Author contributions
MIY, AAH, and MAK conceived, designed and supervised the study; DIS, AEW, and MIY collated experimental data and analyzed them; DIS performed the experiments; MAME performed statistical and molecular docking analyses and prepared the figures; AEW wrote, reviewed and edited the manuscript; All authors have read and agreed to the submitted version of the manuscript.
Funding
Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).
Data availability
All data generated and analyzed in this study are included in this article.
Declarations
Competing interests
The authors declare no competing interests.
Ethics approval
All experiments were performed in accordance with relevant guidelines and regulations. The study has been approved by the Ethics Committee of Alexandria University, Egypt.
Footnotes
References
Associated Data
Data Availability Statement
All data generated and analyzed in this study are included in this article.